Brief: Peer Reviewed Study Demonstrates MIMEDX's PURION® Processed Placental Allografts Outperforms Standard of Care in Select Mohs Defect Reconstructions
Nov 17 (Reuters) - MiMedx Group Inc MDXG.O :
* PEER REVIEWED STUDY DEMONSTRATES MIMEDX DEHYDRATED HUMAN
AMNION
CHORION MEMBRANE (DHACM) OUTPERFORMS STANDARD OF CARE IN SELECT
MOHS DEFECT RECONSTRUCTIONS
Source text for Eikon: ID:nGNXblR5t8
Further company coverage: MDXG.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on MiMedx
See all newsBrief: Mimedx Announces Favorable Federal Court Ruling In Axiofill® Regulatory Classification Matter
MiMedx Group Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Mimedx To Acquire Sanara Medtech
MiMedx Q2 sales fall less than expected; set to acquire Sanara MedTech
Brief: MiMedx Q2 Sales USD 64.362 Million Vs. IBES Estimate USD 63.5 Million